Company Filing History:
Years Active: 2001-2007
Title: Richard Seton Tedder: Innovator in Viral Polypeptide Research
Introduction
Richard Seton Tedder is a notable inventor based in Kent, GB. He has made significant contributions to the field of viral polypeptides, particularly in relation to post-transfusional non-A non-B hepatitis. With a total of two patents to his name, Tedder's work has implications for diagnostic assays and vaccine formulations.
Latest Patents
Tedder's latest patents include innovations related to viral agents and hepatitis polypeptides. The first patent focuses on a post-transfusional non-A non-B hepatitis viral polypeptide, along with DNA sequences encoding such polypeptides. It also covers expression vectors containing these DNA sequences and hosts transformed by such vectors. The second patent mirrors the first, emphasizing the use of these polypeptides in diagnostic assays and vaccine formulations.
Career Highlights
Richard Seton Tedder has had a distinguished career, working with Glaxo Wellcome Inc., a prominent company in the pharmaceutical industry. His research has contributed to advancements in understanding viral infections and developing potential treatments.
Collaborations
Tedder has collaborated with notable colleagues, including Peter Edmund Highfield and Brian Colin Rodgers. These partnerships have likely enhanced the scope and impact of his research.
Conclusion
Richard Seton Tedder's contributions to the field of viral polypeptides underscore his role as an innovator in medical research. His patents reflect a commitment to advancing diagnostic and therapeutic options for hepatitis.